Search research articles
Contact Us
Filters
Showing results (11-20 of 144) with videos related to
Page
of 15
Sort By:
Hematology/Oncology Clinics of North America
|
May 7, 2021
Developing Precision Medicine for Bladder Cancer
Brendan J Guercio, Gopa Iyer, Jonathan E Rosenberg
Urology
|
December 31, 2016
Editorial Comment
Byron H Lee, Gopa Iyer, Hikmat A Al-Ahmadie
Cancer Research
|
February 5, 2013
Oncogenic activation of Pak1-dependent pathway of macropinocytosis determines BCG entry into bladder cancer cells
Gil Redelman-Sidi, Gopa Iyer, David B Solit, et al.
Therapeutic Advances in Urology
|
May 7, 2019
Pembrolizumab in the treatment of locally advanced or metastatic urothelial carcinoma: clinical trial evidence and experience
Michael Crist, Gopa Iyer, Miles Hsu, et al.
JAAD Case Reports
|
January 22, 2025
Use of dupilumab to manage a grade 3 cutaneous adverse effect from enfortumab vedotin/pembrolizumab treatment in a patient with metastatic urothelial carcinoma
Maura C Gillis, Vanessa R Weir, Cecilia Lezcano, et al.
Urologic Oncology
|
November 23, 2020
Systemic therapy in bladder preservation
Daniel M Girardi, Pooja Ghatalia, Parminder Singh, et al.
European Urology
|
November 21, 2020
Re: Russell E.N. Becker, Alexa R. Meyer, Aaron Brant, et al. Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.016
Gopa Iyer, Bernard H Bochner, Eliezer M Van Allen, et al.
The Journal of Urology
|
November 21, 2025
Combination Strategies to Enhance Bacillus Calmette-Guérin Efficacy for Non-Muscle Invasive Bladder Cancer
Gal Wald, Jacob Lang, Hassan Alkazemi, et al.
The Oncologist
|
August 21, 2024
Reevaluating the role of platinum-based chemotherapy in the evolving treatment landscape for patients with advanced urothelial carcinoma
Tian Zhang, Alan Tan, Amishi Y Shah, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 1, 2014
Bevacizumab shows activity in patients with low-grade serous ovarian and primary peritoneal cancer
Rachel N Grisham, Gopa Iyer, Evis Sala, et al.
Page
of 15
Search research articles
Search
Showing results (11-20 of 144) with videos related to
Sort By:
Page
of 15
Hematology/Oncology Clinics of North America
|
May 7, 2021
Developing Precision Medicine for Bladder Cancer
Brendan J Guercio, Gopa Iyer, Jonathan E Rosenberg
Urology
|
December 31, 2016
Editorial Comment
Byron H Lee, Gopa Iyer, Hikmat A Al-Ahmadie
Cancer Research
|
February 5, 2013
Oncogenic activation of Pak1-dependent pathway of macropinocytosis determines BCG entry into bladder cancer cells
Gil Redelman-Sidi, Gopa Iyer, David B Solit, et al.
Therapeutic Advances in Urology
|
May 7, 2019
Pembrolizumab in the treatment of locally advanced or metastatic urothelial carcinoma: clinical trial evidence and experience
Michael Crist, Gopa Iyer, Miles Hsu, et al.
JAAD Case Reports
|
January 22, 2025
Use of dupilumab to manage a grade 3 cutaneous adverse effect from enfortumab vedotin/pembrolizumab treatment in a patient with metastatic urothelial carcinoma
Maura C Gillis, Vanessa R Weir, Cecilia Lezcano, et al.
Urologic Oncology
|
November 23, 2020
Systemic therapy in bladder preservation
Daniel M Girardi, Pooja Ghatalia, Parminder Singh, et al.
European Urology
|
November 21, 2020
Re: Russell E.N. Becker, Alexa R. Meyer, Aaron Brant, et al. Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.016
Gopa Iyer, Bernard H Bochner, Eliezer M Van Allen, et al.
The Journal of Urology
|
November 21, 2025
Combination Strategies to Enhance Bacillus Calmette-Guérin Efficacy for Non-Muscle Invasive Bladder Cancer
Gal Wald, Jacob Lang, Hassan Alkazemi, et al.
The Oncologist
|
August 21, 2024
Reevaluating the role of platinum-based chemotherapy in the evolving treatment landscape for patients with advanced urothelial carcinoma
Tian Zhang, Alan Tan, Amishi Y Shah, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 1, 2014
Bevacizumab shows activity in patients with low-grade serous ovarian and primary peritoneal cancer
Rachel N Grisham, Gopa Iyer, Evis Sala, et al.
Page
of 15